Iodohippuric acid

Generic Name: Iodohippuric acid

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₉H_₈INO_₃

CAS Number: 147-58-0

Unique Ingredient Identifier: 3Y68K91A3M

Background: Iodohippuric acid is under investigation in clinical trial NCT02599844 (Impact of Pediatric Acute Renal Injury in Severe Sepsis in Young Adults).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Impact of Pediatric Acute Renal Injury in Severe Sepsis in Young Adults

Withdrawn

Conditions: Chronic Kidney Disease
Acute Kidney Injury
Hypertension

Interventions: Drug: Iodohippurate
Procedure: 24 hour ambulatory Blood Pressure
Procedure: Peripheral Arterial Tonometry
Procedure: Pulse Wave Velocity
Drug: Gadolinium

First Posted Date: 2015-11-09

Last Posted Date: 2020-03-27

Lead Sponsor: University of Florida

Registration Number: NCT02599844

Severe Sepsis in Children - IMPRESS-C

Withdrawn

Conditions: Acute Kidney Injury
Hypertension
Chronic Kidney Disease

Interventions: Drug: Iodohippurate
Procedure: 24 hour ambulatory Blood Pressure
Procedure: Pulse Wave Velocity
Procedure: Peripheral Arterial Tonometry
Drug: Gadolinium

First Posted Date: 2015-11-06

Last Posted Date: 2020-12-09

Lead Sponsor: University of Florida

Registration Number: NCT02598674

Locations: 🇺🇸
UF Health, Gainesville, Florida, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy